EG
Therapeutic Areas
Tevard Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Dravet Syndrome / Genetic Epilepsies | Dravet syndrome and other Developmental and Epileptic Encephalopathies (DEEs) | Preclinical |
| TTN-related Dilated Cardiomyopathy | Dilated Cardiomyopathy caused by truncating variants in Titin (TTN) | Preclinical |
| Duchenne Muscular Dystrophy (nonsense mutation) | Duchenne Muscular Dystrophy caused by nonsense mutations | Preclinical |